CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day ...
CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...
CLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Published in the journal Pain Medicine, “Comparison of Percutaneous 60-Day Peripheral Nerve Stimulation of the Lumbar Medial Branches to Usual Care with ...
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter study that demonstrated significant and sustained pain ...
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- ...
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR ® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or ...